Zimmer's stock receives "buy" rating from Canaccord Genuity: 5 points

Spinal Tech

Canaccord Genuity has given Zimmer's stock a "buy" rating, according to a Dakota Financial News report.

Here are five points:

 

1. Canaccord Genuity currently has a $150 price target on the stock.

 

2. The company also has a consensus rating of "buy" from other equities research analysts.

 

3. Zimmer Holdings has a 52-week low of $94.73 and a 52-week high of $121.84.

 

4. The stock's 50-day moving average is $113 and its 200-day moving average is $115.

 

5. The company has a market cap of $19.32 billion.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers